Cerus - 27 Year Stock Price History | CERS
Historical daily share price chart and data for Cerus since 1997 adjusted for splits and dividends. The latest closing stock price for Cerus as of December 20, 2024 is 1.58.
- The all-time high Cerus stock closing price was 80.50 on December 28, 2000.
- The Cerus 52-week high stock price is 2.58, which is 63.3% above the current share price.
- The Cerus 52-week low stock price is 1.38, which is 12.7% below the current share price.
- The average Cerus stock price for the last 52 weeks is 1.92.
| Cerus Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2024 | 1.9185 | 2.1600 | 2.4200 | 1.5200 | 1.5800 | -26.85% |
| 2023 | 2.2750 | 3.7400 | 3.8100 | 1.2500 | 2.1600 | -40.82% |
| 2022 | 4.7679 | 6.9900 | 6.9900 | 3.3800 | 3.6500 | -46.40% |
| 2021 | 6.3033 | 6.9400 | 7.9300 | 4.7900 | 6.8100 | -1.59% |
| 2020 | 5.8744 | 4.2500 | 8.5600 | 2.8700 | 6.9200 | 63.98% |
| 2019 | 5.3073 | 5.3400 | 6.8500 | 3.8400 | 4.2200 | -16.77% |
| 2018 | 5.9496 | 3.5600 | 7.7800 | 3.5600 | 5.0700 | 50.00% |
| 2017 | 3.3151 | 4.3300 | 4.6100 | 2.0200 | 3.3800 | -22.30% |
| 2016 | 5.8151 | 6.2400 | 7.3900 | 4.2200 | 4.3500 | -31.17% |
| 2015 | 5.0900 | 6.5150 | 6.5900 | 3.8600 | 6.3200 | 1.28% |
| 2014 | 4.7555 | 6.4800 | 7.9500 | 3.5000 | 6.2400 | -3.26% |
| 2013 | 5.0364 | 3.1900 | 6.9400 | 2.9500 | 6.4500 | 104.11% |
| 2012 | 3.3740 | 2.8600 | 4.3200 | 2.7600 | 3.1600 | 12.86% |
| 2011 | 2.7593 | 2.4800 | 3.5700 | 1.9800 | 2.8000 | 13.82% |
| 2010 | 2.8919 | 1.8000 | 3.9300 | 1.7800 | 2.4600 | 23.62% |
| 2009 | 1.4225 | 0.8200 | 2.9800 | 0.6200 | 1.9900 | 184.29% |
| 2008 | 4.3830 | 6.5600 | 7.2400 | 0.5800 | 0.7000 | -89.25% |
| 2007 | 6.9439 | 5.6800 | 10.1800 | 5.1300 | 6.5100 | 11.09% |
| 2006 | 7.9441 | 10.0100 | 14.4800 | 5.3100 | 5.8600 | -42.27% |
| 2005 | 5.7493 | 3.1000 | 11.3300 | 3.0500 | 10.1500 | 244.07% |
| 2004 | 2.9397 | 4.5000 | 4.7100 | 1.8500 | 2.9500 | -35.02% |
| 2003 | 7.4799 | 21.7200 | 21.7200 | 3.4000 | 4.5400 | -78.88% |
| 2002 | 33.4212 | 46.7700 | 58.6800 | 11.8700 | 21.5000 | -53.01% |
| 2001 | 55.9461 | 69.7500 | 75.3500 | 33.6300 | 45.7500 | -39.20% |
| 2000 | 49.3281 | 24.8800 | 80.5000 | 24.8800 | 75.2500 | 183.96% |
| 1999 | 23.9083 | 20.5000 | 31.2500 | 15.4400 | 26.5000 | 26.19% |
| 1998 | 16.4542 | 22.0000 | 23.7500 | 12.0000 | 21.0000 | -4.55% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.293B | $0.156B |
| Cerus Corporation is developing medical products based on a platformtechnology that prevents nucleic acid replication. The company's initialapplication of this technology is the development of systems to inactivateviruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including pathogen inactivation of source plasma used for fractionation, improving the outcomes of stem cell transplantation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $194.987B | 24.87 |
| Stryker (SYK) | United States | $136.147B | 30.68 |
| Boston Scientific (BSX) | United States | $130.670B | 37.57 |
| EssilorLuxottica (ESLOY) | France | $110.026B | 0.00 |
| Medtronic (MDT) | Ireland | $102.570B | 15.24 |
| Haleon (HLN) | United Kingdom | $43.909B | 28.53 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.293B | 0.00 |
| GE HealthCare Technologies (GEHC) | United States | $35.376B | 18.35 |
| ResMed (RMD) | United States | $33.995B | 27.93 |
| Terumo (TRUMY) | Japan | $28.800B | 40.67 |
| Koninklijke Philips (PHG) | Netherlands | $23.527B | 18.01 |
| Zimmer Biomet Holdings (ZBH) | United States | $21.064B | 13.41 |
| Insulet (PODD) | United States | $17.996B | 71.67 |
| Baxter (BAX) | United States | $14.756B | 9.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.838B | 0.00 |
| BellRing Brands (BRBR) | United States | $10.021B | 40.32 |
| Bio-Rad Laboratories (BIO) | United States | $9.125B | 31.01 |
| Demant (WILYY) | Denmark | $7.926B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.392B | 14.85 |
| Prestige Consumer Healthcare (PBH) | United States | $3.886B | 19.33 |
| Haemonetics (HAE) | United States | $3.862B | 18.85 |
| ICU Medical (ICUI) | United States | $3.751B | 35.71 |
| Perrigo (PRGO) | Ireland | $3.510B | 10.33 |
| Envista Holdings (NVST) | United States | $3.103B | 23.11 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.010B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.894B | 18.63 |
| GN Store Nord (GNNDY) | Denmark | $2.864B | 18.36 |
| Neogen (NEOG) | United States | $2.605B | 30.05 |
| LeMaitre Vascular (LMAT) | United States | $2.074B | 50.41 |
| Green Thumb Industries (GTBIF) | United States | $1.630B | 28.52 |
| AtriCure (ATRC) | United States | $1.465B | 0.00 |
| InMode (INMD) | Israel | $1.444B | 8.68 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.371B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.304B | 9.32 |
| BioLife Solutions (BLFS) | United States | $1.211B | 0.00 |
| Owens & Minor (OMI) | United States | $0.973B | 7.60 |
| CeriBell (CBLL) | United States | $0.958B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.955B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.883B | 15.58 |
| Evolus (EOLS) | United States | $0.688B | 0.00 |
| Omeros (OMER) | United States | $0.593B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.593B | 26.15 |
| Capricor Therapeutics (CAPR) | United States | $0.587B | 0.00 |
| Surmodics (SRDX) | United States | $0.572B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.445B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
| Quanterix (QTRX) | United States | $0.383B | 0.00 |
| ZimVie (ZIMV) | United States | $0.373B | 31.44 |
| Valneva SE (VALN) | France | $0.353B | 0.00 |
| Biote (BTMD) | United States | $0.313B | 6.86 |
| Viemed Healthcare (VMD) | United States | $0.312B | 29.70 |
| Canopy Growth (CGC) | Canada | $0.295B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.283B | 18.95 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| Zynex (ZYXI) | United States | $0.268B | 56.00 |
| High Tide (HITI) | Canada | $0.237B | 98.00 |
| Aurora Cannabis (ACB) | Canada | $0.225B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.211B | 14.54 |
| MacroGenics (MGNX) | United States | $0.200B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.188B | 2.64 |
| Organigram Holdings (OGI) | Canada | $0.184B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.181B | 0.00 |
| Brainsway (BWAY) | Israel | $0.169B | 89.60 |
| FitLife Brands (FTLF) | United States | $0.151B | 19.04 |
| Jin Medical (ZJYL) | China | $0.132B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.110B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.104B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 10.79 |
| Veru (VERU) | United States | $0.092B | 0.00 |
| Exagen (XGN) | United States | $0.083B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.066B | 34.17 |
| InterCure (INCR) | Israel | $0.061B | 0.00 |
| Apyx Medical (APYX) | United States | $0.059B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.054B | 0.00 |
| Modular Medical (MODD) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.042B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.006B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.001B | 0.00 |
| United-Guardian (UG) | United States | $0.000B | 12.82 |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |